247 related articles for article (PubMed ID: 215175)
1. One-year study of the effect of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):429-33. PubMed ID: 215175
[TBL] [Abstract][Full Text] [Related]
2. Dose-response study of bezafibrate on serum lipoprotein concentrations in hyperlipoproteinanemia.
Olsson AG; Lang PD
Atherosclerosis; 1978 Dec; 31(4):421-8. PubMed ID: 215174
[TBL] [Abstract][Full Text] [Related]
3. Dose-response study of the effect of ciprofibrate on serum lipoprotein concentrations in hyperlipoproteinaemia.
Olsson AG; Orö L
Atherosclerosis; 1982 Apr; 42(2-3):229-43. PubMed ID: 6951582
[TBL] [Abstract][Full Text] [Related]
4. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
Weisweiler P; Schwandt P
Klin Wochenschr; 1977 Aug; 55(16):791-4. PubMed ID: 198601
[TBL] [Abstract][Full Text] [Related]
5. On the rise in low density and high density lipoproteins in response to the treatment of hypertriglyceridaemias in type IV and type V hyperlipoproteinaemias.
Carlson LA; Olsson G; Ballantyne D
Atherosclerosis; 1977 Apr; 26(4):603-9. PubMed ID: 193526
[TBL] [Abstract][Full Text] [Related]
6. Lipoprotein composition and lipoprotein interrelations in 50-year-old men with hyperlipoproteinaemia.
Vessby B; Hedstrand H; Olsson U
Ups J Med Sci; 1976; 81(2):71-8. PubMed ID: 183321
[TBL] [Abstract][Full Text] [Related]
7. Reduced LDL- and increased HDL-apoproteins in patients with hypercholesterolaemia under treatment with bezafibrate.
Mordasini R; Riesen W; Oster P; Keller M; Middelhoff G; Lang PD
Atherosclerosis; 1981 Oct; 40(2):153-8. PubMed ID: 6796096
[TBL] [Abstract][Full Text] [Related]
8. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
Kesäniemi YA; Grundy SM
JAMA; 1984 May; 251(17):2241-6. PubMed ID: 6368883
[TBL] [Abstract][Full Text] [Related]
9. Effects of two different fibric acid derivatives on lipoproteins, cholesteryl ester transfer, fibrinogen, plasminogen activator inhibitor and paraoxonase activity in type IIb hyperlipoproteinaemia.
Durrington PN; Mackness MI; Bhatnagar D; Julier K; Prais H; Arrol S; Morgan J; Wood GN
Atherosclerosis; 1998 May; 138(1):217-25. PubMed ID: 9678787
[TBL] [Abstract][Full Text] [Related]
10. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
Gustafson A
Postgrad Med J; 1975; 51(8):suppl 66-71. PubMed ID: 215983
[No Abstract] [Full Text] [Related]
11. Treatment of primary mixed hyperlipidemia with etophylline clofibrate: effects on lipoprotein-modifying enzymes, postprandial lipoprotein metabolism, and lipoprotein distribution and composition.
Föger B; Tröbinger G; Ritsch A; Lechleitner M; Hopferwieser T; Menzel HJ; Utermann G; Pfeiffer KP; Patsch JR
Atherosclerosis; 1995 Oct; 117(2):253-61. PubMed ID: 8801871
[TBL] [Abstract][Full Text] [Related]
12. Serum lipoprotein lipids after gemfibrozil treatment.
Schwandt P; Weisweiler P; Neureuther G
Artery; 1979 Feb; 5(2):117-24. PubMed ID: 231950
[TBL] [Abstract][Full Text] [Related]
13. Effect of gemfibrozil on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Olsson AG; Rössner S; Walldius G; Carlson LA
Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):28-31. PubMed ID: 190607
[TBL] [Abstract][Full Text] [Related]
14. Conversion of type III hyperlipoproteinaemia to type IV hyperlipoproteinaemia by a fat-free, carbohydrate rich diet.
Vessby B; Carlson LA
Eur J Clin Invest; 1975 Jul; 5(4):359-64. PubMed ID: 170119
[TBL] [Abstract][Full Text] [Related]
15. Long-term effect of the combination of calcium clofibrate and calcium carbonate on serum total cholesterol, triglyceride and high density lipoprotein--cholesterol concentrations in hyperlipoproteinaemia. A comparative study with clofibrate.
Lehtonen A; Viikari J
Atherosclerosis; 1979 May; 33(1):49-58. PubMed ID: 223601
[TBL] [Abstract][Full Text] [Related]
16. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
Falko JM; Witztum JL; Schonfeld G; Weidman SW; Kolar JB
Am J Med; 1979 Feb; 66(2):303-10. PubMed ID: 218451
[No Abstract] [Full Text] [Related]
17. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
Patsch JR; Yeshurun D; Jackson RL; Gotto AM
Am J Med; 1977 Dec; 63(6):1001-9. PubMed ID: 204188
[No Abstract] [Full Text] [Related]
18. Effect of BM 15.075 on lipoprotein concentrations in different types of hyperlipoproteinaemia.
Olsson AG; Rössner S; Walldius G; Carlson LA; Lang PD
Atherosclerosis; 1977 Jul; 27(3):279-87. PubMed ID: 901625
[TBL] [Abstract][Full Text] [Related]
19. Effect of clofibrate on the composition of very low and low density lipoprotein subfractions in type III hyperlipoproteinaemia.
Ballantyne D; Ballantyne FC; Stromberg P; Third JL; Bedford DK
Clin Chim Acta; 1978 Feb; 83(1-2):117-22. PubMed ID: 202421
[TBL] [Abstract][Full Text] [Related]
20. Acute effect of dietary therapy of type IV hyperlipoproteinaemia on the serum and lipoprotein concentrations and relative composition.
Ballantyne D; Olsson AG; Carlson LA
Atherosclerosis; 1978 May; 30(1):79-87. PubMed ID: 209798
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
